Avantor, Inc. Deferred Income Tax Expense (Benefit)
Avantor, Inc. (AVTR) reported Deferred Income Tax Expense (Benefit) of -$10.20 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-04-29
- Avantor, Inc. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was -$10.20M.
- Avantor, Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $49.60M, a 74.65% increase year-over-year.
- Avantor, Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was -$11.90M.
- Avantor, Inc. deferred income tax expense (benefit) for the quarter ending 2025-06-30 was -$17.60M.
- Avantor, Inc. deferred income tax expense (benefit) for fiscal 2025 was $7.70M.
- Avantor, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$46.90M.
- Avantor, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$172.40M.
- Avantor, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$69.10M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$10.20M 10-Q · filed 2026-04-29 | $39.40M derived: sum of 2 quarters · filed 2026-04-29 | $27.50M derived: sum of 3 quarters · filed 2026-04-29 | $9.90M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $49.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $37.70M derived: sum of 2 quarters · filed 2026-02-11 | $20.10M derived: sum of 3 quarters · filed 2026-02-11 | $7.70M 10-K · filed 2026-02-11 |
| 2025-09-30 | -$11.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$29.50M derived: sum of 2 quarters · filed 2025-10-29 | -$41.90M 10-Q · filed 2025-10-29 | -$13.50M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | -$17.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$30.00M 10-Q · filed 2025-08-01 | -$1.60M derived: sum of 3 quarters · filed 2026-04-29 | -$24.20M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | -$12.40M 10-Q · filed 2026-04-29 | $16.00M derived: sum of 2 quarters · filed 2026-04-29 | -$6.60M derived: sum of 3 quarters · filed 2026-04-29 | -$41.40M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | $28.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $5.80M derived: sum of 2 quarters · filed 2026-02-11 | -$29.00M derived: sum of 3 quarters · filed 2026-02-11 | -$46.90M 10-K · filed 2026-02-11 |
| 2024-09-30 | -$22.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | -$57.40M derived: sum of 2 quarters · filed 2025-10-29 | -$75.30M 10-Q · filed 2025-10-29 | -$153.60M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -$34.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | -$52.70M 10-Q · filed 2025-08-01 | -$131.00M derived: sum of 3 quarters · filed 2026-02-11 | -$160.40M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -$17.90M 10-Q · filed 2025-04-25 | -$96.20M derived: sum of 2 quarters · filed 2026-02-11 | -$125.60M derived: sum of 3 quarters · filed 2026-02-11 | -$163.90M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -$78.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$107.70M derived: sum of 2 quarters · filed 2026-02-11 | -$146.00M derived: sum of 3 quarters · filed 2026-02-11 | -$172.40M 10-K · filed 2026-02-11 |
| 2023-09-30 | -$29.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-25 | -$67.70M derived: sum of 2 quarters · filed 2024-10-25 | -$94.10M 10-Q · filed 2024-10-25 | -$101.40M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | -$38.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-26 | -$64.70M 10-Q · filed 2024-07-26 | -$72.00M derived: sum of 3 quarters · filed 2025-02-07 | -$94.30M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | -$26.40M 10-Q · filed 2024-04-26 | -$33.70M derived: sum of 2 quarters · filed 2025-02-07 | -$56.00M derived: sum of 3 quarters · filed 2025-02-07 | -$73.20M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | -$7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | -$29.60M derived: sum of 2 quarters · filed 2025-02-07 | -$46.80M derived: sum of 3 quarters · filed 2025-02-07 | -$69.10M 10-K · filed 2025-02-07 |
| 2022-09-30 | -$22.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | -$39.50M derived: sum of 2 quarters · filed 2023-10-27 | -$61.80M 10-Q · filed 2023-10-27 | -$55.50M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$17.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | -$39.50M 10-Q · filed 2023-07-28 | -$33.20M derived: sum of 3 quarters · filed 2024-02-14 | -$51.90M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | -$22.30M 10-Q · filed 2023-04-28 | -$16.00M derived: sum of 2 quarters · filed 2024-02-14 | -$34.70M derived: sum of 3 quarters · filed 2024-02-14 | -$34.70M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$12.40M derived: sum of 2 quarters · filed 2024-02-14 | -$12.40M derived: sum of 3 quarters · filed 2024-02-14 | -$17.70M 10-K · filed 2024-02-14 |
| 2021-09-30 | -$18.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | -$18.70M derived: sum of 2 quarters · filed 2022-10-28 | -$24.00M 10-Q · filed 2022-10-28 | -$20.80M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | -$5.30M 10-Q · filed 2022-07-29 | -$2.10M derived: sum of 3 quarters · filed 2023-02-14 | -$70.70M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$5.30M 10-Q · filed 2022-04-29 | -$2.10M derived: sum of 2 quarters · filed 2023-02-14 | -$70.70M derived: sum of 3 quarters · filed 2023-02-14 | -$88.60M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$65.40M derived: sum of 2 quarters · filed 2023-02-14 | -$83.30M derived: sum of 3 quarters · filed 2023-02-14 | -$87.50M 10-K · filed 2023-02-14 |
| 2020-09-30 | -$68.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | -$86.50M derived: sum of 2 quarters · filed 2021-10-29 | -$90.70M 10-Q · filed 2021-10-29 | -$129.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | -$17.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$22.10M 10-Q · filed 2021-07-30 | -$61.30M derived: sum of 3 quarters · filed 2022-02-11 | -$68.50M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | -$4.20M 10-Q · filed 2021-04-28 | -$43.40M derived: sum of 2 quarters · filed 2022-02-11 | -$50.60M derived: sum of 3 quarters · filed 2022-02-11 | -$89.40M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | -$39.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$46.40M derived: sum of 2 quarters · filed 2022-02-11 | -$85.20M derived: sum of 3 quarters · filed 2022-02-11 | -$106.70M 10-K · filed 2022-02-11 |
| 2019-09-30 | -$7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | -$46.00M derived: sum of 2 quarters · filed 2020-10-27 | -$67.50M 10-Q · filed 2020-10-27 | -$35.70M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | -$38.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$60.30M 10-Q · filed 2020-07-29 | -$28.50M derived: sum of 3 quarters · filed 2021-02-16 | -$89.30M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | -$21.50M 10-Q · filed 2020-04-29 | $10.30M derived: sum of 2 quarters · filed 2021-02-16 | -$50.50M derived: sum of 3 quarters · filed 2021-02-16 | |
| 2018-12-31 | $31.80M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$29.00M derived: sum of 2 quarters · filed 2021-02-16 | -$103.90M 10-K · filed 2021-02-16 | |
| 2018-09-30 | -$60.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$135.70M 10-Q · filed 2019-11-05 | ||
| 2018-06-30 | -$74.90M 10-Q · filed 2019-08-06 | |||
| 2017-12-31 | -$430.60M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |